Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

PropertyValue
has major subject area list Neoplasm Recurrence, Local; Proto-Oncogene Proteins p21(ras); Quinolones; Salivary Gland Neoplasms
information resource reference Hanna GJ, Guenette JP, Chau NG, Sayehli CM, Wilhelm C, Metcalf R, Wong DJ, Brose M, Razaq M, PĂ©rez-Ruiz E, Cohen EEW, Aggarwal R, Scholz C, Gualberto A, Ho AL. Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer. Cancer. 2020 09 01; 126(17):3972-3981.
label Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

Search Criteria
  • Salivary Gland Cancers